SPDW - ETF AI Analysis

Top Page

SPDR Portfolio Developed World ex-US ETF (SPDW)

Rating:62Neutral

Price Target:―

SPDW, the SPDR Portfolio Developed World ex-US ETF, has a solid overall rating driven by high-quality global leaders like Novartis, HSBC, Toyota, and AstraZeneca, which all show strong financial health, positive earnings commentary, and generally supportive technical or valuation trends. Additional support comes from stable, cash-generative companies such as Nestlé and Royal Bank of Canada, though some holdings like Roche and SAP face valuation or technical pressures that slightly weigh on the fund. The main risk factor is its concentration in large non-U.S. companies and sectors where some stocks appear expensive or near overbought levels, which could lead to short-term volatility.

Positive Factors

Very Low Expense Ratio

The fund charges a very low fee, which helps investors keep more of their returns over time.

Broad International Diversification

Holdings spread across many developed countries like Japan, the UK, and Europe help reduce the impact of problems in any single market.

Generally Positive Recent Performance

The ETF has shown steady gains over the past month, three months, and year-to-date, indicating supportive recent market conditions for its holdings.

Negative Factors

Concentration in Financials and Industrials

A large share of the portfolio is in financial and industrial companies, which can hurt returns if these sectors face a downturn.

Mixed Performance Among Top Holdings

While some leading positions have performed strongly, others have been weak, which can create uneven results for the fund.

Limited Exposure to the U.S. Market

Because the ETF focuses on developed markets outside the U.S., investors relying on it alone may miss out on parts of the U.S. stock market’s performance.

SPDW vs. SPDR S&P 500 ETF (SPY)

AUM36.21B

RegionDeveloped Markets

Expense Ratio0.03%

Beta0.71

IssuerSPDR

Inception DateApr 20, 2007

Dividend Yield3.12%

Asset ClassEquity

Index TrackedS&P Developed x United States BMI

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume4,528,882

30 Day Avg. Volume4,450,655

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

52.15

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering2076

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

SPDW Summary

SPDR Portfolio Developed World ex-US ETF (SPDW) is a fund that tracks the S&P Developed ex-U.S. Index, giving you broad stock market exposure to developed countries outside the United States, such as Japan, the UK, and Europe. It owns hundreds of companies across many sectors, including well-known names like Toyota and Nestlé. Investors might consider SPDW to diversify beyond the U.S. market and tap into long-term growth in other major economies with one simple investment. A key risk is that international stocks can be volatile and will rise or fall with global markets and currency swings.

How much will it cost me?The SPDR Portfolio Developed World ex-US ETF (SPDW) has an expense ratio of 0.03%, which means you’ll pay $0.30 per year for every $1,000 invested. This is lower than average because it’s a passively managed fund that tracks an index, keeping costs minimal.

What would affect this ETF?SPDW could benefit from global economic growth and technological advancements, especially given its exposure to developed markets and top holdings like ASML and Samsung Electronics. However, it may face challenges from rising interest rates, geopolitical tensions, or sector-specific risks, such as fluctuations in energy prices or regulatory changes in healthcare and financial sectors.

SPDW Top 10 Holdings

SPDW leans on a global mix of developed-market giants, with Europe and Asia doing most of the heavy lifting. ASML and Samsung are the clear pace-setters, riding strong momentum in global chip and tech demand. Health care names like Roche and Novartis are providing steady ballast, while AstraZeneca looks a bit more mixed. On the defensive side, Nestlé and SAP have been losing steam lately, quietly tugging on returns. Financials such as HSBC and Royal Bank of Canada add another pillar, underscoring the fund’s broad, sector-diversified ex-U.S. profile.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
ASML	ASML Holding NV	1.75%	$631.69M	€464.34B	67.81%	76 Outperform
SMSN	Samsung Electronics	1.68%	$607.84M	$713.22B	203.64%	―
ROG	Roche Holding AG	1.00%	$360.59M	CHF279.83B	41.58%	73 Outperform
HSBA	HSBC Holdings	0.96%	$345.21M	£220.77B	51.99%	80 Outperform
NOVN	Novartis AG	0.92%	$331.08M	CHF218.15B	19.92%	80 Outperform
AZN	AstraZeneca	0.90%	$323.59M	£210.86B	19.89%	80 Outperform
7203	Toyota Motor	0.87%	$315.53M	¥45.67T	17.84%	80 Outperform
NESN	Nestlé SA	0.79%	$286.33M	CHF185.72B	12.00%	71 Outperform
RY	Royal Bank Of Canada	0.74%	$267.49M	$233.00B	36.33%	75 Outperform
SIE	Siemens	0.71%	$258.20M	€199.98B	24.44%	74 Outperform

SPDW Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

44.54

Positive

100DMA

43.47

Positive

200DMA

41.23

Positive

Market Momentum

MACD

0.78

Negative

RSI

62.84

Neutral

STOCH

77.41

Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SPDW, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 46.25, equal to the 50-day MA of 44.54, and equal to the 200-day MA of 41.23, indicating a bullish trend. The MACD of 0.78 indicates Negative momentum. The RSI at 62.84 is Neutral, neither overbought nor oversold. The STOCH value of 77.41 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SPDW.

SPDW Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
SPDW	―	―	$36.21B	0.03%	―
VEA	―	―	$209.76B	0.03%	―
SCHF	―	―	$59.19B	0.03%	―
IDEV	―	―	$26.22B	0.04%	―
IQLT	―	―	$14.49B	0.30%	―
DFAI	―	―	$14.02B	0.18%	―

Performance Comparison

SPDW

SPDR Portfolio Developed World ex-US ETF

46.98

12.97

38.14%

VEA

Vanguard FTSE Developed Markets ETF

―

SCHF

Schwab International Equity ETF

―

IDEV

iShares Core MSCI International Developed Markets ETF

―

IQLT

iShares MSCI Intl Quality Factor ETF

―

DFAI

Dimensional International Core Equity Market ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents